首页 | 本学科首页   官方微博 | 高级检索  
     

利奈唑胺治疗院内MRSA肺炎的临床评价
引用本文:毕鸿雁,杨宏军,田风. 利奈唑胺治疗院内MRSA肺炎的临床评价[J]. 西南科技大学学报(哲学社会科学版), 2009, 7(6): 38-39
作者姓名:毕鸿雁  杨宏军  田风
作者单位:昆明医学院第一附属医院干疗科,650031
摘    要:目的 评价利奈唑胺治疗院内MRSA肺炎的临床疗效和安全性。方法 回顾分析13例MRSA感染的住院患者接受利奈唑胺治疗临床资料。结果 临床治愈13例,不良反应发生率7.7%。结论 应用利奈唑胺治疗院内MRSA肺炎能取得显著的临床效果及满意的细菌清除率,可作为院内MRSA肺炎的有效用药。

关 键 词:利奈唑胺  MRSA肺炎  院内

Clinical evaluation of linezolid for MRSA-related HAP
BI Hongyan,YANG Hongjun,TIAN Feng. Clinical evaluation of linezolid for MRSA-related HAP[J]. Journal of Southwest University of Science and Technology, 2009, 7(6): 38-39
Authors:BI Hongyan  YANG Hongjun  TIAN Feng
Affiliation:.(The department of Geratology,The first affiliated hospital of Kunming Medical College,Yunnan Province,650032 China.)
Abstract:Objective To evaluate therapeutic effect and drug safety of Linezolid in MRSA-related Hospital-associated Pneumonia(HAP) therapy. Methods Retrospective analysis the clinical of 13 patients,suffered form MRSA-related HAP,who treated with Linezolid. Results All patients get cured at clinical therapy criterion,and medicine adverse-reaction rate is 7.7%. Conclusion Linezolid could provide conspicuous effectiveness and satisfactory bacterium clearance rate in treatment of MRSA-related HAP,which would become the effective medicine for this disease.
Keywords:Linezolid,MRSA-related,Hospital-associated Pneumonia(HAP)
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号